{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:40:52Z","timestamp":1793148052037,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.eprac.2025.01.011","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:08:27Z","timestamp":1739300907000},"page":"668-676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Polycystic Ovary Syndrome in East Asia: A\u00a0Review and Meta-Analysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Zhao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guining","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5078-4566","authenticated-orcid":false,"given":"Renyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.eprac.2025.01.011_bib1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/humrep\/deac091","article-title":"Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019","volume":"37","author":"Safiri","year":"2022","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.eprac.2025.01.011_bib2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/jog.14132","article-title":"Phenotype and genotype of polycystic ovary syndrome in Asia: ethnic differences","volume":"45","author":"Kim","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and north africa: data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"7755","key":"10.1016\/j.eprac.2025.01.011_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1171-x","article-title":"Rising rural body-mass index is the main driver of the global obesity epidemic in adults","volume":"569","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.011_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia--as common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"39","key":"10.1016\/j.eprac.2025.01.011_bib9","doi-asserted-by":"crossref","first-page":"14172","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0004-28032015000200008","article-title":"Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome","volume":"52","author":"Romanowski","year":"2015","journal-title":"Arq Gastroenterol"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.011_bib11","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.011_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"21","key":"10.1016\/j.eprac.2025.01.011_bib13","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.27869","article-title":"Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study","volume":"62","author":"VanWagner","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.eprac.2025.01.011_bib15","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijerph15112589","article-title":"Geographical prevalence of polycystic ovary syndrome as determined by region and race\/ethnicity","volume":"15","author":"Wolf","year":"2018","journal-title":"Int J Environ Res Publ Health"},{"issue":"7414","key":"10.1016\/j.eprac.2025.01.011_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"issue":"7109","key":"10.1016\/j.eprac.2025.01.011_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.011_bib18","first-page":"4259","article-title":"Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"issue":"14","key":"10.1016\/j.eprac.2025.01.011_bib19","first-page":"3177","article-title":"Association between hyperandrogenism and the onset of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"36","author":"Wang","year":"2021","journal-title":"Maternal Child Health Care China"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.011_bib20","first-page":"32","article-title":"Risk factors for patients with polycystic ovary syndrome complicated with non-alcoholic fatty liver disease","volume":"6","author":"Qin","year":"2023","journal-title":"Bachu Medical J"},{"issue":"9","key":"10.1016\/j.eprac.2025.01.011_bib21","first-page":"725","article-title":"The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS","volume":"11","author":"Qu","year":"2013","journal-title":"Iran J Reproductive Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.011_bib22","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.1038\/s41598-021-86697-y","article-title":"Non-alcoholic fatty liver disease in polycystic ovary syndrome women","volume":"11","author":"Won","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib23","first-page":"128","article-title":"Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?","volume":"63","author":"Di","year":"2019","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib24","first-page":"123","article-title":"Changes of androgen levels in polycystic ovary syndrome patients with non-alcoholic fatty disease","volume":"23","author":"Xie","year":"2015","journal-title":"Chin J Diabetes"},{"issue":"12","key":"10.1016\/j.eprac.2025.01.011_bib25","first-page":"37","article-title":"Prevalence of non-alcoholic fatty liver among patients with polycystic syndrome","volume":"33","author":"Zhao","year":"2011","journal-title":"J Ningxia Medical University"},{"issue":"7","key":"10.1016\/j.eprac.2025.01.011_bib26","first-page":"1","volume":"1","author":"Z","year":"2014","journal-title":"Shanghai Jiao Tong University"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib27","first-page":"198","article-title":"Association of non-alcoholic fatty liver disease and polycystic ovary syndrome","volume":"13","author":"Huang","year":"2010","journal-title":"J Clin Hepatol"},{"issue":"9","key":"10.1016\/j.eprac.2025.01.011_bib28","first-page":"817","article-title":"Association of non-alcoholic fatty liver disease with polycystic ovarian syndrome","volume":"33","author":"Ha","year":"2011","journal-title":"Ningxia Med J"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib29","first-page":"507","article-title":"Doppler ultrasound diagnosis of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"49","author":"Fan","year":"2015","journal-title":"J Harbin Med Univ"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib30","first-page":"622","article-title":"Effect of changes in androgen levels in polycystic ovary syndrome with non-alcoholic fatty liver disease","volume":"25","author":"Deng","year":"2020","journal-title":"Chin Hepatol"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib31","first-page":"751","article-title":"Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompa nied with non-alcoholic fatty liver disease","volume":"33","author":"Chen","year":"2013","journal-title":"Chinese J Integrated Traditional Chinese Western Medicine"},{"issue":"11","key":"10.1016\/j.eprac.2025.01.011_bib32","first-page":"5360","article-title":"Sex hormone characteristics in patients with polycystic ovarian syndrome (phlegm dampness syndrome) and nonalcoholic fatty liver disease","volume":"34","author":"Gu","year":"2019","journal-title":"Chinese J Traditional Chinese Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.011_bib33","first-page":"82","article-title":"Retrospective analysis of Doppler ultrasound for polycystic ovary syndrome with nonalcoholic fatty liver disease","volume":"22","author":"An","year":"2017","journal-title":"Chin Hepatol"},{"issue":"19","key":"10.1016\/j.eprac.2025.01.011_bib34","first-page":"183","article-title":"Analysis of the incidence of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"20","author":"Wu","year":"2016","journal-title":"J Clin Med Practice"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib35","first-page":"804","article-title":"Analysis of the incidence of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"36","author":"Sun","year":"2020","journal-title":"J Mod Med Health"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib36","first-page":"52","article-title":"Clinical analysis of PCOS patients with non-alcoholic fatty liver disease","volume":"51","author":"Zhou","year":"2013","journal-title":"China Modern Doctor"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib37","first-page":"98","article-title":"Analysis of the incidence of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"43","author":"Zheng","year":"2008","journal-title":"Chin J Obstet Gynecol"},{"issue":"29","key":"10.1016\/j.eprac.2025.01.011_bib38","first-page":"2036","article-title":"Effect of obesity on non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"90","author":"Qu","year":"2010","journal-title":"Chin Med J"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib39","first-page":"201","article-title":"Investigation of the risk factors associated with polycystic ovary syndrome associated with non-alcoholic fatty liver disease","volume":"40","author":"Li","year":"2020","journal-title":"Chin J Reprod Contracep"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib40","first-page":"688","article-title":"Study on the relationship between nonalcoholic fatty liver disease in polycystic ovary syndrome and the polymorphisms of adiponectin gene","volume":"33","author":"Jing","year":"2010","journal-title":"Master\u2019s Dissertation of North China Coal Medical College"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib41","first-page":"389","article-title":"Analysis of sex hormen levels patients with phlegm dampness type polycystic ovary syndrome with or without nonalcoholic fatty liver disease","volume":"3","author":"Gu","year":"2017","journal-title":"Heilongjiang University of Traditional Chinese Medicine Master Dissertation"},{"issue":"28","key":"10.1016\/j.eprac.2025.01.011_bib42","first-page":"98","article-title":"Association of triglyceride-glucose index with risk of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome","volume":"18","author":"Fu","year":"2021","journal-title":"China Medical Herald"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib43","first-page":"856","article-title":"Changes of insulin resistance index, lipid and adiponectin in patients with polycystic ovary syndrome complicated with nonalcoholic fatty liver","volume":"33","author":"Fan","year":"2011","journal-title":"Hebei Med J"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.011_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12978-018-0519-2","article-title":"A\u00a0potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis","volume":"15","author":"Wu","year":"2018","journal-title":"Reprod Health"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib45","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40618-023-02210-4","article-title":"Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome","volume":"47","author":"Fruzzetti","year":"2024","journal-title":"J\u00a0Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.011_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0974-1208.112370","article-title":"Prevalence of hepatic steatosis in women with polycystic ovary syndrome","volume":"6","author":"Karoli","year":"2013","journal-title":"J\u00a0Hum Reprod Sci"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/jc.2010-1608","article-title":"Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome","volume":"96","author":"Ma","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"44","key":"10.1016\/j.eprac.2025.01.011_bib49","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.3748\/wjg.v26.i44.7046","article-title":"Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome","volume":"26","author":"Shengir","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.eprac.2025.01.011_bib50","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s10815-021-02291-1","article-title":"Replication study and meta-analysis of selected genetic variants and polycystic ovary syndrome susceptibility in Asian population","volume":"38","author":"Wan","year":"2021","journal-title":"J\u00a0Assist Reprod Genet"},{"issue":"9403","key":"10.1016\/j.eprac.2025.01.011_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.eprac.2025.01.011_bib52","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions-2019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"10.1016\/j.eprac.2025.01.011_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/DMSO.S182331","article-title":"Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease","volume":"12","author":"Szanto","year":"2019","journal-title":"Diabetes, Metab Syndrome Obes Targets Ther"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib55","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"issue":"11","key":"10.1016\/j.eprac.2025.01.011_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib57","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"issue":"5","key":"10.1016\/j.eprac.2025.01.011_bib59","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.eprac.2025.01.011_bib60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.eprac.2025.01.011_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/biomedicines10010131","article-title":"Prevalence, risk factors, and pathophysiology of nonalcoholic fatty liver disease (NAFLD) in women with polycystic ovary syndrome (PCOS)","volume":"10","author":"Spremovi\u0107 Ra\u0111enovi\u0107","year":"2022","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.eprac.2025.01.011_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib63","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib64","first-page":"11","article-title":"Role of non-alcoholic fatty liver disease in cardiovascular morbidity in polycystic ovarian syndrome","volume":"70","author":"Nath","year":"2022","journal-title":"J\u00a0Assoc Phys India"},{"issue":"6","key":"10.1016\/j.eprac.2025.01.011_bib65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.eprac.2025.01.011_bib66","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s40618-017-0708-9","article-title":"Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis","volume":"40","author":"Rocha","year":"2017","journal-title":"J\u00a0Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.eprac.2025.01.011_bib67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.eprac.2025.01.011_bib68","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-16-1063","article-title":"Management of endocrine disease: polycystic ovary syndrome and nonalcoholic fatty liver disease","volume":"177","author":"Macut","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2025.01.011_bib69","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jsbmb.2013.04.001","article-title":"Androgen (dihydrotestosterone)-mediated regulation of food intake and obesity in female mice","volume":"138","author":"Kanaya","year":"2013","journal-title":"J\u00a0Steroid Biochem Mol Biol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:57:52Z","timestamp":1762549072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1530891X25000400"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.01.011","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Polycystic Ovary Syndrome in East Asia: A\u00a0Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}